Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
FEBS Lett ; 592(21): 3493-3503, 2018 11.
Artigo em Inglês | MEDLINE | ID: mdl-29962039

RESUMO

Membrane fusion is a key event in exocytosis of neurotransmitters and hormones stored in intracellular vesicles. In this process, soluble N-ethylmaleimide sensitive factor attachment protein receptor (SNARE) proteins are essential components of the exocytotic molecular machinery, while lipids have been seen traditionally as structural elements. However, the so-called signalling lipids, such as sphingosine and arachidonic acid, interact with SNAREs and directly modulate the frequency and mode of fusion events. Interestingly, recent work has proved that the sphingosine analogue FTY-720, used in the treatment of multiple sclerosis, mimics the effects of signalling lipids. In the present Review, we discuss recent investigations suggesting that endogenous signalling lipids and synthetic analogues can modulate important physiological aspects of secretion, such as quantal release, vesicle recruitment into active sites, vesicle transport and even organelle fusion in the cytosol. Therefore, these compounds are far from being merely structural components of cellular membranes.


Assuntos
Ácido Araquidônico/metabolismo , Exocitose/fisiologia , Transdução de Sinais , Esfingosina/metabolismo , Animais , Humanos , Fusão de Membrana , Ligação Proteica , Proteínas SNARE/metabolismo
2.
Sci Rep ; 7(1): 5958, 2017 07 20.
Artigo em Inglês | MEDLINE | ID: mdl-28729700

RESUMO

Neurotransmission and secretion of hormones involve a sequence of protein/lipid interactions with lipid turnover impacting on vesicle trafficking and ultimately fusion of secretory vesicles with the plasma membrane. We previously demonstrated that sphingosine, a sphingolipid metabolite, promotes formation of the SNARE complex required for membrane fusion and also increases the rate of exocytosis in isolated nerve terminals, neuromuscular junctions, neuroendocrine cells and in hippocampal neurons. Recently a fungi-derived sphingosine homologue, FTY720, has been approved for treatment of multiple sclerosis. In its non-phosphorylated form FTY720 accumulates in the central nervous system, reaching high levels which could affect neuronal function. Considering close structural similarity of sphingosine and FTY720 we investigated whether FTY720 has an effect on regulated exocytosis. Our data demonstrate that FTY720 can activate vesicular synaptobrevin for SNARE complex formation and enhance exocytosis in neuroendocrine cells and neurons.


Assuntos
Cloridrato de Fingolimode/uso terapêutico , Esclerose Múltipla/tratamento farmacológico , Esclerose Múltipla/metabolismo , Sistemas Neurossecretores/metabolismo , Proteínas R-SNARE/metabolismo , Esfingosina/análogos & derivados , Vesículas Sinápticas/metabolismo , Animais , Citosol/efeitos dos fármacos , Citosol/metabolismo , Potenciais Pós-Sinápticos Excitadores/efeitos dos fármacos , Exocitose/efeitos dos fármacos , Cloridrato de Fingolimode/química , Cloridrato de Fingolimode/farmacologia , Ácido Glutâmico/metabolismo , Hipocampo/patologia , Hipocampo/fisiopatologia , Masculino , Esclerose Múltipla/fisiopatologia , Neurônios/efeitos dos fármacos , Neurônios/metabolismo , Sistemas Neurossecretores/efeitos dos fármacos , Sistemas Neurossecretores/patologia , Sistemas Neurossecretores/fisiopatologia , Ratos Wistar , Proteínas SNARE/metabolismo , Vesículas Sinápticas/efeitos dos fármacos , Sinaptossomos/efeitos dos fármacos , Sinaptossomos/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA